NTRK2 and Alzheimer disease: Besides of BDNF‐TrkB signaling, our results show the new insight into the APOE‐PP2A and the autophagy system involved in the neuroprotection of rTMS on AD, which provides more experimental evidence for clinical applications of rTMS in the treatment of AD.